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Glycosylation of flagellin is essential for the virulence ofCampylobacter jejuni, a leading cause of
bacterial gastroenteritis. Here, we demonstrate comprehensive mapping of the O-glycosylation
of flagellin from Campylobacter jejuni 11168 by use of a bottom-up proteomics approach that
incorporates differential ion mobility spectrometry (also known as high field asymmetric wave-
form ion mobility spectrometry or FAIMS) together with proteolysis with proteinase K. Pro-
teinase K provides complementary sequence coverage to that achieved following trypsin pro-
teolysis. The use of FAIMS increased the number of glycopeptides identified. Novel glycans
for this strain were identified (pseudaminic acid and either acetamidino pseudaminic acid or
legionaminic acid), as were novel glycosylation sites: Thr208, Ser343, Ser348, Ser349, Ser395,
Ser398, Ser423, Ser433, Ser436, Ser445, Ser448, Ser451, Ser452, Ser454, Ser457 and Thr465.
Multiply glycosylated peptides were observed, as well as variation at individual residues in the
nature of the glycan and its presence or absence. Such extreme heterogeneity in the pattern of
glycosylation has not been reported previously, and suggests a novel dimension in molecular
variation within a bacterial population that may be significant in persistence of the organism in
its natural environment. These results demonstrate the usefulness of differential ion mobility
in proteomics investigations of PTMs.
Keywords:
Campylobacter jejuni 11168 / Flagellin A / Glycoproteomics / Glycosylation / LC
FAIMS MS/MS / Proteinase K / Trypsin
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1 Introduction
Campylobacter jejuni is the most prevalent foodborne bacte-
rial agent of diarrhoeal disease in humans worldwide [1].
This zoonosis enters the human diet from poultry and farm
animal sources in which the organism causes little pathol-
ogy [2]. Disease in humans is usually self-limiting and rel-
atively short-lived although symptoms can be severe, such
Correspondence: Prof. Helen J. Cooper, School of Biosciences,
University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
E-mail: h.j.cooper@bham.ac.uk.
Abbreviations: AGC, automatic gain control; FAIMS, field asym-
metric waveform ion mobility spectrometry
that healthcare and economic impact are considerable [3]. A
minority of cases lead to more serious sequelae such as
Guillain–Barre´ motor neuropathy [4], the most common
cause of general paralysis in developed countries since the
eradication of poliomyelitis.
Virulence factors are not fully understood but it is clear that
flagellar motility is crucial in the colonisation by the organ-
ism of digestive tracts in birds [5,6], hence is also likely to be
required for infection in humans, a conclusion supported by
experimental infection in human subjects [7]. The flagellum
is not only responsible for motility of campylobacters, but is
also responsible for secretion of important colonisation and
virulence factors, reviewed in [8]. The flagellar filament pro-
tein, flagellin, is both a dominant antigen important as a tar-
get of immune reactivity [9], and a receptor for bacteriophage
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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attack [10]. A recent report demonstrated the involvement of
flagellin glycan residues in phage receptor activity [11]. Hence
there are strong selective pressures that may drive molecular
variation in the flagellin molecule, with important implica-
tions in the control of infection.
Flagellins FlaA (major, ca. 90% of total) and FlaB, the ma-
jor structural protein monomers of the flagellar filament, are
proteins each of 572 amino acid residues totalling approxi-
mately 59 kDa, although apparent Mr determined by SDS-
PAGE is about 10% higher, due to the presence of numerous
glycan residues: for an overview see [12]. The two proteins
are 94% identical in amino acid sequence, with very few
differences in the glycosylated non-terminal portion of the
molecule that is known to be exposed on the surface of the
assembled structure.Wehave therefore taken the sequence of
FlaA as the basis for our observations and refer to it through-
out as ‘flagellin’. Although it has been shown in strains 81–
176 [13, 14] and NCTC 11168 [15] that a number of specific
amino acid residues of flagellin may be O-glycosylated, it is
unclear whether these modifications are always present or
whether there is variation within the population of molecules
in the nature of the glycan or the extent of glycosylation. Flag-
ellin is rich especially in serine (approx. 11% of residues in
strain 11168 and the most commonly modified residue) and
also in threonine (approx. 6%) but many of these residues
have not been shown to be targets for modification. It is not
known how specific residues are selected for glycosylation
or whether this process is tightly controlled or stochastic in
nature.
MS was first applied to the analysis of glycosylation of flag-
ellins fromCampylobacter jejuni (81–176, 11168 andOH4384)
and Campylobacter coli (VC167 T2) by Thibault et al. [16]. The
major glycans identified were pseudaminic acid and deriva-
tives thereof. Further work on C. coli (VC167) revealed the
presence of legionaminic acid and derivatives [17]. Previously
in our laboratory [18] we applied LC electron capture dissocia-
tionMS/MS (LCECDMS/MS) to the analysis of glycosylation
inflagellin fromCampylobacter jejuni 11168, revealing that the
protein was modified by dimethyl glyceric acid derivatives
of pseudaminic acid and acetamidino pseudaminic acid at
Ser181, Ser207 and either Thr 464 or Thr465. That work was
in agreement with the work of Logan et al. who first identified
these novel glycans [19]. Although the LC ECD MS/MS ap-
proach was successful in identifying the presence and site of
glycosylation in flagellin fromC. jejuni 11168, therewas an ex-
tensive region of the protein (residues 387–463) for which no
coverage was achieved. This observation is particularly salient
as the homologous region in flagellin from C. jejuni 81–176
is heavily glycosylated [16]. Moreover, the region contains nu-
merous potential sites of O-glycosylation, 21 serine residues
and four threonine residues, affording the opportunity for
differential glycosylation within the region. Any (non-tryptic)
proteolysis within the region is therefore likely to result in a
complex mixture comprising multiple glycopeptide isomers
and isobars.
In order to address the limited flagellin coverage obtained
with trypsin, we have applied an alternative protease for the
analysis of flagellin, that is, proteinase K. Proteinase K has
a broad specificity and cleaves peptide bonds that are C-
terminal to aliphatic and aromatic residues [20]. It has been
previously successfully applied to the analysis of glycopro-
teins [21, 22]. Given the broad specificity of proteinase K and
the likelihood of extensive glycosylation in the region of in-
terest, we also incorporated gas-phase fractionation in the
form of high field asymmetric waveform ion mobility spec-
trometry (FAIMS), in the workflow. FAIMS separates ions
at atmospheric pressure on the basis of differences in their
differential ion mobility. We, and others, have shown that
FAIMS is useful in extending proteome coverage [23–25].
We have also shown that FAIMS is capable of separating
glycopeptide isomers [26]. Here, we demonstrate comprehen-
sivemapping ofO-glycosylation in flagellin fromCampylobac-
ter jejuni 11168 by use of this multienzyme differential ion
mobility approach.
2 Materials and methods
2.1 Preparation of flagellin A
Campylobacter jejuni (NCTC 11168) cultures were grown on
Mueller Hinton agar (Oxoid Ltd., Basingstoke, UK) and incu-
bated in microaerophilic conditions (90% N2, 4% O2, and 6%
CO2 at 37C) for 30 h. Cells were harvested from 13 separate
agar plates and suspended in 5.7 mL of Luria-Bertani Broth.
The suspensionwas homogenised at high speed (20 500 rpm)
using an Ultra Turrax T-25 homogeniser, for 2 min, with 30 s
rest, for four cycles in order to shear the flagellar filament
from the bacterial wall. The homogenate was centrifuged at
7500 rpm for 20 min at 4C to remove cells and cell debris.
The supernatant was collected and treated with 1% Triton
X (Bio-Rad), incubated at 37C for 45 min, and subjected to
ultracentrifugation (TL-100 Ultracentrifuge, TLA-100.3 fixed
angle rotor, maximum RCF 541000 × g, Beckman, USA) at
50 000 rpm for 1 h at 4C. The supernatant was removed im-
mediately, tubes inverted on filter paper to remove residual
fluid, and the resulting pellets were re-suspended in 100 L
distilled water. A 5 L aliquot of the sample was analysed
by SDS-PAGE, and visualised using Coomassie stain R250
(Bio-Rad) to check flagellar protein purity, see Supporting In-
formation Fig. 1. A further 5 L was subjected to a Bradford
protein assay to measure the protein concentration. The re-
maining sample was stored at –20C until further analysis.
Two biological replicates were considered.
2.2 Trypsin digestion
For LC MS/MS analysis, 10 L of sample (7 g of the ex-
tracted flagellar protein) was made up to 100 L in 100 mM
of ammonium bicarbonate (Fluka Analytical, UK)) and
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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denatured by incubating at 95C for 5 min. Trypsin (Sigma
Aldrich, Dorset, UK) (1 g/L in 50 mM acetic acid (Sigma
Aldrich, Dorset, UK)) was added to the mixture to give 1:50
(replicate#1) or 1:7 (replicate#2) ratio of enzyme to protein,
and incubated overnight at 37C with mild shaking. Proteoly-
sis was quenched by freezing at –20C and the sample stored
until further analysis. For LC FAIMSMS/MS analysis, 50 g
of protein were digested using the digestion procedure as
above.
2.3 Proteinase K digestion
Approximately 84 L of the sample (70 g of the extracted
flagellar protein) was made up to 100 L in 100 mM of am-
monium bicarbonate (Fluka Analytical, UK) and denatured
at 95C for 5 min. Proteinase K (Sigma Aldrich, Dorset, UK)
(1 g/L in 50 mM Tris-HCl (Fisher Scientific, Loughbor-
ough, UK), 5 mM CaCl2 (BHD laboratory, England)) was
added to the mixture to give a 1:1 (replicate#1) or 1:100 (repli-
cate#2) ratio of enzyme to protein, and incubated for 1 h
(replicate#1) or 2 h (replicate#2) at 37C with mild shaking.
Proteolysiswas quenched by freezing at –20Cand the sample
stored until further analysis.
Both trypsin- and proteinase K-treated samples were de-
salted using C18 column zip tips (Merck Millipore Ltd.,
Germany) (according tomanufacturers’ instructions). Briefly,
the tips were wetted using 100% acetonitrile (J.T., Baker, Hol-
land), and then equilibrated using 0.1% trifluoroacetic acid
(Fisher Scientific Loughborough, UK). The samples were as-
pirated and dispensed for 10 cycles, and then washed three
times using 0.1%TFA and eluted using 70:30 acetonitrile and
0.1%TFA.The desalted sampleswere dried and re-suspended
in 10 L of 0.1% formic acid prior to MS analysis.
2.4 LC-MS/MS
Peptides were separated using online reversed phase LC
(Dionex Ultimate 3000) using a binary solvent system con-
sisting of mobile phase A (water (J.T., Baker, Holland)/0.1%
formic acid (Fisher Scientific, Loughborough, UK)) and mo-
bile phase B (acetonitrile, (J.T., Baker, Holland)/0.1% formic
acid (Fisher Scientific Loughborough, UK)). Sixmicroliters of
the desalted samples were loaded onto a 150 mm Acclaim R©
Pepmap 100 C18 column and separated by a 30 min gradi-
ent from 3.2 to 44% of mobile phase B, followed by 10 min
at 90% of mobile phase B and 16 min with 3.2% mobile
phase B to re-equilibrate the system. The LC was coupled
to an Advion Triversa Nanomate (Advion, Ithaca, USA) that
infused the peptides at a spray voltage of 1.7 kV. Peptides
were infused directly into the Thermo Orbitrap Velos ETD
mass spectrometer (Thermo Fisher Scientific) at a flow rate of
0.35 L/min.
The mass spectrometer alternated between a full FT-MS
scan (m/z 380–1600) and subsequentCIDandETDof the four
most abundant precursor ions. Survey scans were acquired
in the Orbitrap with a resolution of 60 000 at m/z 400. Only
multiply charged precursor ions were selected for MS/MS.
The dynamic exclusion was used with a repeat count of 1 for
30 s. Automatic gain control (AGC) was used to accumulate
sufficient precursor ions. AGC target value for FT-MS was
1 × 106 charges. CID was performed in the linear ion trap
using helium at normalised collision energy of 35%. Width
of the precursor isolation window was 2 Th. AGC target was
5 × 104 charges with maximum injection time of 100 ms.
Charge state-dependant ETD was performed in the linear ion
trap with activation time 100 ms. Isolation window was 3 Th.
AGC target of ETD was performed with fluoranthene ions.
AGC target was 5 × 104 charges with maximum injection
time of 100 ms. Supplemental activation was enabled with
activation energy of 25%. Data acquisition was controlled by
Xcalibur 2.1 (Thermo Fisher Scientific).
2.5 FAIMS
The LCwas coupled to the FAIMS device (Thermo Fisher Sci-
entific), though a modified nanospray HESI II heated elec-
trospray source, similar to that used by Swearingen et al.
[25], incorporating a Picotip emitter needle (New Objective,
Woburn, USA). The spray voltage was 3 kV. For FAIMS the
dispersion voltage was –5000 V, inner and outer electrode
temperatures were 70C and 90C, respectively. The gas flow
was 2.9 L/min, consisting of 50:50 helium and nitrogen. Sep-
arate LC-FAIMS-MS/MS analyses were performed at the fol-
lowing compensation voltages: –20 V, –25 V, –30 V, –35 V,
–40 V, –45 V, –50 V and –55 V (trypsin replicate #2; proteinase
K replicate #2); –20 V, –25 V, –30 V, –35 V, –40 V, –45 V and
–50 V ((trypsin replicate #1); –15 V, –20 V, –25 V, –30 V,
–35 V, –40 V and –45 V (proteinase K replicate #1). LC and
MS/MS method was the same as described above.
2.6 Data analysis
Raw data were loaded into ProteomeDiscoverer (version 1.4).
Precursors with a mass of less than 350 Da and greater
than 5000 Da were excluded and MS/MS spectra were re-
quired to have at least 1 peak. The CID and ETD spectra
were separated and searched with the same parameters ex-
cept for the fragment ions (b and y ions for CID and c, y
and z ions for ETD). Data were searched against a manu-
ally created Campylobacter flagellin database (886 sequences)
or a Campylobacter flagellin 11168 database (59 sequences)
with sequences from the NCBI nr database. The data were
searched using both the SEQUEST and Mascot algorithms
(controlled through Proteome Discover version 1.4, Mascot
version 2.4). In both SEQUEST and Mascot searches, the
following parameters were used: precursor ion m/z toler-
ance 10 ppm; fragment ion tolerance 0.5 Da; enzyme—either
trypsin or nonspecific enzyme (proteinase K); maximum
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Scheme 1. Structures of glycans identified in the protein database searches (based on findings in [19], [16], and [17]).
number of missed cleavages = 2; no fixed modifications; dy-
namic modifications as described below. Multiple searches
of the data were performed with different combinations of
dynamic modifications (maximum number of dynamic mod-
ifications per search = 6). The glycans considered were as
described in [18]. The following combinations of dynamic
modificationswere considered: (A) oxidation+15.995Da (M),
C13H20N2O7,+ 316.127 Da, (S/T), C16H27N3O8 + 389.180 Da
(S/T), C13H21N3O6 + 315.143 Da (S/T) and C16H26N2O9 +
390.164 (S/T); (B) oxidation +15.995 Da (M), C16H27N3O8 +
389.180Da (S/T), C16H26N2O9 + 390.164 (S/T), C15H24N2O11
+ 408.138 Da (S/T), C20H31N5O9, +485.212 Da (S/T), and
C15H22N2O8, + 358.137 Da (S/T); (C) oxidation +15.995
Da (M), C16H27N3O8 + 389.180 Da (S/T), C16H26N2O9 +
390.164 (S/T), C13H20N2O7 + 316.127Da (S/T), C20H30N4O10
+ 486.196 Da (S/T) and C14H23N3O6 + 329.1587 (S/T);
(D) oxidation +15.995 Da (M), C13H20N2O7 +316.127 Da
(S/T), C13H21N3O6 + 315.143 Da (S/T), C15H24N2O11 +
408.138 Da (S/T), C20H31N5O9, +485.212 Da (S/T), and
C15H22N2O8, + 358.137 Da (S/T); (E) oxidation +15.995 Da
(M), C13H20N2O7 +316.127 Da (S/T), C13H21N3O6 + 315.143
Da (S/T), C20H30N4O10 + 486.196 Da (S/T) and C14H23N3O6
+329.1587 (S/T) and C16H26N2O9 + 390.164 (S/T); (F) ox-
idation +15.995 Da (M), C16H27N3O8 + 389.180 Da (S/T),
C16H26N2O9 + 390.164 (S/T), C13H20N2O7 +316.127 Da
(S/T), C13H21N3O6 + 315.143 Da (S/T), and C15H24N2O11 +
408.138 Da (S/T). Glycopeptide identities were confirmed by
manual analysis using the MS product package in Protein
Prospector (http://prospector.ucsf.edu/prospector/mshome
.htm).
3 Results and discussion
3.1 Trypsin proteolysis and LC MS/MS
In our previous paper [18], we used a combination of trypsin
proteolysis and LC ECD MS/MS. Here, we have used a CID-
ETD method where each precursor ion is sequentially frag-
mented with CID and ETD. For comparison purposes, we
first analysed the flagellin digest by LC CID ETD MS/MS
without FAIMS. The data were searched against Campy-
lobacter protein databases, using the Mascot and SEQUEST
algorithms. A range of glycans were considered in the
database searches as described in the experimental section.
The glycans identified were dimethylglyceric acid derivative
of pseudaminic acid (C16H26N2O9, m 390.164); dimethyl-
glyceric acid derivative of 7-acetamidino pseudaminic acid
(C16H27N3O8, m 389.180), pseudaminic acid (C13H20N2O7,
m 316.127), acetamidino pseudaminic acid/legionaminic
acid (C13H21N3O6, m 315.143). The structures of these gly-
cans are shown inScheme1. For convenience, the glycanswill
hereafter be referred to by their mass shift (m390, m389,
m316, m315).
The combined protein sequence coverage obtained from
the two replicates with CID was 76.2%. Eighteen glycopep-
tides were identified in the two database searches, however
manual analysis of themass spectra revealed that in each case
fragmentation was poor and the peptide sequence coverage
insufficient to assign sites of glycosylation. The combined
protein sequence coverage obtained for ETD was 76.2%, see
Fig. 1. Nine glycopeptides were assigned in the database
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 1. Sequence coverage
obtained from ETD MS/MS for
tryptic digest (no FAIMS) (green),
tryptic digest (with FAIMS) (red);
proteinase K digest (no FAIMS)
(yellow); proteinase K (with
FAIMS) (pink).
search of the ETD data, but in this case, the fragmentation
spectra were of sufficient quality to assign the modification
sites in all but one case. Table 1 summarises the glycopep-
tides identified. (Unmodified peptides are summarised in
Supporting Information Table 1). The ETD MS/MS spec-
tra for the glycopeptides are shown in Supporting Infor-
mation Fig. 2. Although the ETD mass spectra are bet-
ter suited for localisation of sites of glycosylation, the CID
mass spectra are useful in confirming the nature of the
glycan: Each CID mass spectrum of a glycopeptide con-
tains peak(s) corresponding to glycan oxonium ions, see
below.
Seven of the glycopeptides identified were modified by
m389 or by m390, five of which were at Ser181, Ser207
and Thr 464 or Thr465. These combinations of glycan and
modification site were seen in our previous work. Two of the
glycopeptides were glycosylated by these glycans at Ser345
and 349. These sites of glycosylation have not been observed
previously. Two of the glycopeptides are modified by m315,
one at Ser181 and one at Ser207. Modification of flagellin A
from Campylobacter jejuni 11168 by this glycan has not been
observed previously.
As observed previously, no sequence coverage was ob-
served between amino acid residues 387 and 463. This region
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Table 2. Glycopeptides identified from proteinase K digest of flagellin following ETD MS/MS (without FAIMS)
Peptide sequence Glycans Site Charge
state
m/zmeas m/zcalc  ppm CV #1 #2
Proteinase K proteolysis and LC MS/MS
RFETGGRISTS m390 Ser181 3+ 534.2614 534.2653 –7.3 n/a √
KVVISTSVGTGL m389 Ser207 3+ 517.2893 517.2943 –9.7 n/a √
KVVISTSVGT m390 Ser207 3+ 460.9164 460.9205 –8.9 n/a √
KVVISTSVGT m389 Ser207 3+ 460.5884 460.5925 –8.9 n/a √
SLVKNDGKDILISGS m389 Ser343a) 3+ 645.6748 645.6809 –9.4 n/a √
SLVKNDGKDILISGS m390 Ser343a) 3+ 646.0026 646.0089 –9.6 n/a √
DGKDILISGS m389 Ser343a) 2+ 697.3502 697.3565 –9.0 n/a √ √
LVKNDGKDILISGS m389 Ser343a) 3+ 616.6645 616.6702 –9.2 n/a √
DGKDILISGS m390 Ser343a) 2+ 697.8419 697.8485 –9.4 n/a √ √
DGKDILISGS m315 Ser343a) 3+ 440.5617 440.5612 1.2 n/a √
NDGKDILISGS m389 Ser343a) 3+ 503.2496 503.2544 –9.5 n/a √ √
NDGKDILISGS m315 Ser343a) 3+ 478.5761 478.5755 1.3 n/a √
GGYSSVSAY m315, m390 Ser395 Ser398a) 3+ 532.5648 532.5702 –9.8 n/a √ √
GGYSSVSAY m315, m389 Ser395 Ser398a) 3+ 532.2426 532.2422 0.8 n/a √
GSGFSSGSGYSVG m316, m315, m389 Ser409, Ser410,
Ser412 Ser415
3+ 853.3694 853.3766 –8.4 n/a √
NYSTGFAN m389 Ser423a) 2+ 631.7742 631.7804 –9.7 n/a √
KTTAFGVKDETAGVT m390 Thr465a) 3+ 638.9835 638.9896 –9.5 n/a √
a) Indicates novel glycan and/or glycosylation site. Note that where peptides were identified from both replicates,m/zmeas values are given
for replicate#2. Glycosylated residues are underlined and in bold.
of the protein has a high concentration of serine and threo-
nine residues and may be heavily glycosylated, as observed
in C. jejuni 81–168 [16]. The region is also characterised by
a scarcity of lysine and arginine residues. Only two large
peptides are predicted to result from trypsin proteolysis, one
containing 11 and one containing 14 potentialO-glycosylation
sites.
3.2 Tryspin proteolysis and LC FAIMS MS/MS
Trypsin digests of flagellin were analysed by use of LC FAIMS
MS/MS with the top-4 MS method. An ‘external CV step-
ping’ FAIMS method [23] was applied in which multiple LC
MS/MS analyses are performed at different compensation
voltages. The total combined protein sequence coverage ob-
tained for ETD was 81.6%, see Fig. 1. Nineteen glycopep-
tides were assigned in the protein database search of the
ETD data. Manual analysis of the data revealed the presence
of 15 glycopeptides, summarised in Table 1. MS/MS spec-
tra are shown in Supporting Information Fig. 3. (Unmod-
ified peptides are summarised in Supporting Information
Table 1).
Seven glycopeptides containing Ser181 were identified,
four ofwhichweremodified bym389 orm390, as observed
previously [18]. The missed-cleavage peptide FETGGRISTS-
GEVQFTLKmodified with m315 was identified in the anal-
ysis conducted at CV = –50 V. Glycosylation by m315 of
the same site in the fully tryptic peptide was also observed in
this analysis (CV= –50 V) and in the analysis without FAIMS
described above. Themissed-cleavage peptide FETGGRISTS-
GEVQFTLK was also identified as modified by m316 in the
analysis at CV = –40 V. This modification of flagellin has not
been observed previously in C. jejuni 11186.
Five glycopeptides containing Ser207 were identified, four
of which were modified by 389 or m390. The remain-
ing peptide was modified by m315 at Ser 207. This com-
bination of glycan/glycosylation site has not been observed
previously. Finally, three peptides were identified which con-
tained Thr464 and Thr465, modified by m389, m390 and
m315. In all cases, although the ETD fragmentation was ex-
tensive, no cleavage between the two threonine residues was
observed precluding unambiguous site localisation. As seen
above, glycosylation of these site(s) by m389 and m315 are
novel observations.
The introduction of FAIMS into the workflow resulted
in observation of novel glycans and combinations of gly-
can/glycosylation sites. Nevertheless, protein coverage be-
tween amino acid residues 388 and 463 was not achieved,
presumably as a result of the use of trypsin as the
protease.
3.3 Proteinase K proteolysis and LC MS/MS
To address the problem of the ‘missing region’, i.e. amino
acid residues 388–463, an alternative protease—proteinase
K —was considered. Two biological replicates were in-
vestigated. For the first, proteolysis conditions were en-
zyme/protein ratio 1:1, 1 h incubation (replicate #1). Sub-
sequent experiments to determine the optimum conditions
(to achieve maximum coverage) for proteolysis by proteinase
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Table 3. Glycopeptides identified from proteinase K digest of flagellin following ETD MS/MS (with FAIMS)
Peptide sequence Glycans Site Charge
state
m/zmeas m/zcalc  ppm CV #1 #2
K proteolysis and LC FAIMS MS/MS
FETGGRISTS m390 Ser181 3+ 482.2289 482.2316 –5.6 –55 √
RFETGGRISTS m390 Ser181 2+ 800.8937 800.8943 –0.7 –30 √
RFETGGRISTS m390 Ser181 3+ 534.2627 534.2653 –4.9 –40, –50,
–55
√
KVVISTSVGT m390 Ser207 2+ 690.8729 690.8770 –6.1 –30 √
KVVISTSVGT m390 Ser207 3+ 460.9183 460.9205 –4.8 –45 √
KVVISTSVGT m389 Ser207 3+ 460.5901 460.5925 –5.2 –40 √
KVVISTSVGT m315 Ser207a) 2+ 653.8559 653.8587 –4.3 –25 √
KVVISTSVGT m390 Thr208a) 3+ 460.9181 460.9205 –5.2 –40 √
KVVISTSVGTGL m390 Ser207 2+ 775.9260 775.9298 –4.9 –20, –25 √
KVVISTSVGTGL m390 Ser207 3+ 517.6198 517.6223 –4.8 –40 √
KVVISTSVGTGL m389 Ser207 3+ 517.2915 517.2943 –5.4 –40 √
GKDILISGS m389 Ser343a) 2+ 639.8397 639.8430 –5.2 –30(#1,#2
35(#1),
40(#1)
√ √
GKDILISGS m389 Ser343a) 3+ 426.898 426.898 0.5 –35 √
GKDILISGS m315 Ser343a) 2+ 602.8246 602.8246 –0.1 –30 √
DGKDILISGS m315 Ser343a) 3+ 440.5618 440.5612 1.4 –40 √
DGKDILISGS m390 Ser343a) 2+ 697.8455 697.8485 –4.3 –25(#1),
–30(#2)
√ √
DGKDILISGS m390 Ser343a) 3+ 465.5656 465.5681 –5.3 –40 √ √
DGKDILISGS m389 Ser343a) 2+ 697.3527 697.3565 –5.4 –30 √ √
DGKDILISGS m389 Ser343a) 3+ 465.2376 465.2401 –5.4 –40 √
NDGKDILISGS m390 Ser343a) 2+ 754.8671 754.8700 –3.8 –25 √
NDGKDILISGS m389 Ser343a) 3+ 503.2518 503.2544 –5.0 –40 √
VKNDGKDILISGS m390 Ser343a) 3+ 579.3001 579.3035 –5.9 –40, –45 √
LVKNDGKDILISGS m390 Ser343a) 2+ 924.9881 924.9937 –6.1 –20, –25 √
LVKNDGKDILISGS m390 Ser343a) 3+ 616.9946 616.9982 –5.8 –35, –40,
–45
√
LVKNDGKDILISGS m389 Ser343a) 3+ 616.6667 616.6702 –5.7 –40 √
SLVKNDGKDILISGS m390 Ser343a) 3+ 646.0053 646.0089 –5.6 –40, –45 √
SLVKNDGKDILISGS m389 Ser343a) 3+ 645.6771 645.6809 –5.9 –40, –45 √
DGKDILISGSNLSSA m389,
m390
Ser343,
Ser348a)
3+ 752.7002 752.7041 –5.2 –40 √
DGKDILISGSNLSSA m389 Ser343,
Ser348/
349a)
3+ 752.3716 752.3761 6.0 –35 √
DGKDILISGSNLSSA m390 Ser343,
S348a)
3+ 753.0285 753.0321 –4.7 –40 √
NDGKDILISGSNLSSA m390 Ser343,
Ser348a)
3+ 791.0425 791.0464 –4.9 –35 √
NDGKDILISGSNLSSA m390,
m389
Ser343,
Ser348a)
3+ 790.7147 790.7184 –4.6 –30, –35 √
LVKNDGKDILISGSNLSSA m389 Ser343,
Ser349a)
3+ 903.8013 903.8062 –5.4 –30 √
NYSTGFAN m389 Ser423a) 2+ 631.7775 631.7804 –4.6 –25 √
NYSTGFAN m390 Ser423a) 2+ 632.2691 632.2724 –5.2 –25 √
AIAISAASQL m390,
m315
Ser433,
Ser436a)
3+ 550.6179 550.6208 –5.3 –40 √
GGYSSVSAY m315,
m389
Ser395
Ser398a)
3+ 532.2392 532.2421 –5.4 –45(#1,2),
–40(#2),
–50(#2)
√ √
GGYSSVSAY m315,
m390
Ser395,
Ser398a)
2+ 798.3481 798.3516 –4.4 –25 √
GGYSSVSAY m315,
m390
Ser395,
Ser398a)
3+ 532.5664 532.5702 –7.1 –45 √
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Table 3. Continued
Peptide sequence Glycans Site Charge
state
m/zmeas m/zcalc  ppm CV #1 #2
SAGSGFSSGSTLSQF m390,
m315,
m316,
m390
Ser445,
Ser451,
Ser452,
Ser457a)
3+ 944.4135 944.4170 –3.7 –30 √
YNVSAGSGFSSGSTLSQF m390,
(m316 or
m315),
(m315 or
m316),
m390
Ser445,
Ser448,
Ser454
Ser457a)
4+ 802.6043 802.6082 –4.9 –40 √
GFSSGSTLSQF m315,
m316,
m 390
Ser452,
Ser454,
Ser457a)
3+ 713.6513 713.6548 –4.9 –40 √
GSGFSSGSGY m316,
m315 site
undeter-
mined
Ser409,
Ser410
2+ 768.8207 768.8205 0.3 –35 √
SGFSSGSTLSQF m389,
m316,
m390
Ser451,
Ser452
Ser457a)
3+ 767.3407 767.3444 –4.8 –40 √
TTAFGVKDETAGVT m390 Thr465 3+ 596.2880 596.2913 –5.5 –40 √
a) Indicates novel glycan and/or glycosylation site. Note that where peptides were identified from both replicates,m/zmeas values are given
for replicate#2. Glycosylated residues are underlined and in bold.
K were performed (data not shown), and conditions found to
be enzyme/protein ratio 1:100, 2 h incubation (replicate #2).
The proteinase K digest of flagellin was first analysed by the
‘top-4’ LC MS/MS method without FAIMS. The combined
protein sequence coverage obtained for ETD was 18.4%, see
Fig. 1. Note that proteinase K has provided access to the ‘miss-
ing region’: the sequence coverage in the region [388–463] is
36.6%.
Twenty glycopeptides were assigned in the database search
of the ETD data, howevermanual analysis of the ETD spectra,
with cross-validation against the corresponding CID spectra,
revealed 17 true assignments, see Table 2. (Unmodified pep-
tides are summarised in Supporting Information Table 2.
Note that no unmodified peptides were identified in replicate
#1). ETD MS/MS spectra are shown in Supporting Informa-
tion Fig. 4. One of the glycopeptides contained Ser181 mod-
ified by m390. Three contained Ser207 glycosylated with
either m389 or m390. These observations support our
earlier work [18]. One of the glycopeptides contained Thr465
modified by m390. In our earlier work and with trypsin
and FAIMS—see above, we showed that either Thr464 or
Thr465 was modified, but we were unable to unambiguously
assign the glycosylation site. Six of the glycopeptides identi-
fied contained the novel glycosylation site Ser343 and were
glycosylated with either m389 or m390. Two of the pep-
tides contained site Ser343 glycosylated with m315. The re-
maining peptides derived from the region inaccessible via
trypsin. Peptide [NYSTGFAN] was shown to be modified
by m389 at Ser423. Peptide [GGYSSVSAY] was multiply
modified by m315 and m390 or m389 at sites Ser395
and 298, respectively. Peptide [GSGFSSGSGYSVG] was mul-
tiply modified by m316, m315, m389 and m389 at sites
Ser409, Ser410, Ser412 and Ser415, respectively.
3.4 Proteinase K proteolysis and LC FAIMS MS/MS
Proteinase K digests were analysed by LC FAIMS MS/MS
(‘external CV stepping’) with the top-4 MS method. The
combined protein sequence coverage obtained for ETD was
39.0%, see Fig. 1. Importantly, the sequence coverage in the
‘missing region’ was 81.5%. The combined coverage from
the proteinase K and trypsin LC FAIMS MS/MS analyses
was 94.1%. Forty-four non-redundant glycopeptides were as-
signed in the database search; however 37 non-redundant
glycopeptides were confirmed by manual analysis and cross-
validation against corresponding CID mass spectra. See
Table 3. (Unmodified peptides are summarised in Support-
ing Information Table 3. Note that no unmodified peptides
were identified in replicate #1). Previously unobserved gly-
cans or glycosylation sites are indicated with an asterisk. Rep-
resentative ETD MS/MS spectra are shown in Fig. 2 and the
remainders are shown in Supporting Information Fig. 5.
Figure 2A shows the ETD mass spectrum of triply charged
ions of multiply-glycosylated peptide GGYSSVSAY modified
at Ser395 and Ser398 with glycans m315 and m389, re-
spectively. This peptide is from the region of the protein
inaccessible by trypsin digestion. The corresponding CID
mass spectrum (shown inset) confirms the nature of the gly-
cans. Oxonium ions are observed at m/z 316 and 390. This
C© 2015 The Authors. PROTEOMICS published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 2. (A) ETDmass spectrumof [M+3H]3+ ions of gly-
copeptide GGYSSVSAY modified at Ser395 and Ser398
with glycans m315 and m389, respectively. Retention
time = 12.88 min. CV = –45 V. Inset: CID mass spec-
trum showing the oxonium ions for glycans m315 and
m389 atm/z 316 andm/z 390. (B) ETDmass spectrum of
[M+4H]4+ ions of glycopeptide YNVSAGSGFSSGSTLSQF
modified at Ser445, Ser448, Ser454, and Ser457 modi-
fied with glycans m390, m316, m316, and m389,
respectively (see text for discussion). Retention time =
19.75 min. CV = –40 V. Inset: CID mass spectrum show-
ing the oxonium ions for glycans m315, m316, m389,
and m390 atm/z 316,m/z 317,m/z 390, andm/z 391. (C)
ETD mass spectrum of [M+3H]3+ ions of glycopeptide
GFSSGSTLSQF modified at Ser 452, Ser454, and Ser457
with glycans m315, m316, and m390, respectively.
Retention time = 19.82 min. CV = –40 V. Inset: CID mass
spectrum showing the oxonium ions for glycans m315,
m316, and m390 atm/z 316,m/z 317, andm/z 391.
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Figure 3. (Top) The number of glycopeptides identified at each of the compensation voltages. (Bottom) Distribution of glycopeptides
identified according to charge state.
peptide was observed at compensation voltages –45 V and
–50 V (as 3+ precursor). Differential glycosylation of this
peptide was observed, i.e. modification at Ser395 and Ser398
with glycans m315 and m390, respectively. That peptide
was observed at CV = –45 V (3+ precursor) and –25 V (2+
precursor).
The ETD spectrum shown in Fig. 2B was obtained for
quadruply charged multiply glycosylated YNVSAGSGFSS-
GSTLSQF. The precursor ionmass suggests glycan combina-
tions (i) m316, m316, m389 and m390; or (ii) m315,
m316, m390 and m390. Given the well-established
propensity for hydrogen transfer among ETD fragments
(z, z+1, c, c-1), there is scope for ambiguity in the ETD
mass spectrum. The corresponding CID mass spectrum re-
veals oxonium ions at m/z 316, 317, 390 and 391 suggesting
both species are present; however, the relative abundances
of the oxonium ions suggests that (ii) is the predominant
species. It is not possible to confirm unambiguously the sites
of the m315 and m316 glycans within the glycopeptide
because of the potential for hydrogen transfer between ETD
Figure 4. Summary of the sites
of glycosylation observed fol-
lowing multienzyme differential
ion mobility mass spectrometry
of flagellin from Campylobacter
jejuni 11168.
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fragments. The glycans are sited on Ser448 and Ser454 (or a
combination of the two). Figure 2C shows a third example of
a multiply glycosylated peptide from the previously inacces-
sible region.
Figure 3 (top) shows the number of glycopeptides identi-
fied at each of the various compensation voltages in replicate
#2. The greatest number of identifications was achieved at a
compensation voltage of –40 V. The distribution of glycopep-
tides identified according to charge state is shown in Fig. 3
(bottom). Doubly charged glycopeptides ions were observed
between CVs of –20 and –30 V; triply charged glycopeptides
between –30 and –55 V. Two 4+ glycopeptides ions were ob-
served at –35 and –40 V. The majority of the identifications
were of triply charged precursors.
4 Concluding remarks
We have demonstrated that comprehensive mapping of the
O-glycosylation of flagellin from Campylobacter jejuni 11168
may be achieved by incorporating differential ion mobility
spectrometry into the bottom-up proteomics workflow, to-
gether with use of both trypsin and proteinase K for pro-
teolysis. A summary of the sites of glycosylation observed
is given in Fig. 4. Novel glycans for this strain have been
identified (pseudaminic acid and either acetamidino pseu-
daminic acid or legionaminic acid), as have novel glycosyla-
tion sites: Thr208, Ser343, Ser348, Ser349, Ser395, Ser398,
Ser423, Ser433, Ser436, Ser445, Ser448, Ser451, Ser452,
Ser454, Ser457 and Thr465. Multiply and differentially glyco-
sylated peptides were observed: the identity of the glycan at
modified amino acid residueswas variable, and both presence
and absence of glycan at specific residues was also observed.
The observed heterogeneity in glycosylation patterns thus ap-
pears to confer a combinatorial element of biological variation
in the flagellin, potentially advantageous to selective survival
of members of the population in the face of biological attack.
These results further demonstrate the usefulness of differen-
tial ion mobility in proteomics investigations of PTMs.
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